Technical Analysis for MYO - Myomo Inc.

Grade Last Price % Change Price Change
grade F 5.9 -7.09% -0.45
MYO closed down 7.09 percent on Tuesday, February 25, 2020, on 55 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical MYO trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction -7.09%
Wide Bands Range Expansion -7.09%
Down 3 Days in a Row Weakness -7.09%
Oversold Stochastic Weakness -7.09%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -14.12%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


Myomo, Inc. is a commercial stage medical robotics Company that offers expanded mobility for those suffering from neurological disorders and upper limb paralysis. Based on patented technology developed at MIT and the Company, Myomo develops and markets the MyoPro® product line of lightweight, non-invasive, powered arm braces to restore function in the paralyzed or weakened arms and hands of individuals that have suffered a stroke, spinal cord or nerve injury such as brachial plexus injury, or other neuromuscular disability such as amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS). It is provided through clinical relationships with VA medical centers, leading rehabilitation hospitals, and Orthotics and Prosthetics (“O&P”) practices. Several hundred have been successfully used by patients. It is the only device that, sensing a patient’s own neurological signals through non-invasive sensors on the arm, can restore their ability to use their arms and hands so that they can return to work, live independently and reduce their cost of care. Myomo is headquartered in Cambridge, Massachusetts, with sales and clinical professionals across the U.S. For more information, please visit
Medical Specialties Organ Systems Multiple Sclerosis Neurological Disorders Amyotrophic Lateral Sclerosis Stroke Podiatry Skeletal System Muscular System Neurotrauma Orthopedics

Is MYO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 45.0
52 Week Low 5.28
Average Volume 732,515
200-Day Moving Average 18.83
50-Day Moving Average 9.91
20-Day Moving Average 9.63
10-Day Moving Average 6.37
Average True Range 3.38
ADX 24.26
+DI 31.62
-DI 22.79
Chandelier Exit (Long, 3 ATRs ) 29.88
Chandelier Exit (Short, 3 ATRs ) 15.41
Upper Bollinger Band 20.71
Lower Bollinger Band -1.46
Percent B (%b) 0.33
BandWidth 230.37
MACD Line -1.29
MACD Signal Line -0.82
MACD Histogram -0.4747
Fundamentals Value
Market Cap 35.92 Million
Num Shares 6.09 Million
EPS -8.54
Price-to-Earnings (P/E) Ratio -0.69
Price-to-Sales 14.12
Price-to-Book 4.12
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.09
Resistance 3 (R3) 7.15 6.83 6.89
Resistance 2 (R2) 6.83 6.52 6.79 6.82
Resistance 1 (R1) 6.36 6.34 6.20 6.30 6.76
Pivot Point 6.04 6.04 5.96 6.00 6.04
Support 1 (S1) 5.57 5.73 5.41 5.51 5.04
Support 2 (S2) 5.25 5.55 5.21 4.98
Support 3 (S3) 4.78 5.25 4.91
Support 4 (S4) 4.72